OBJECTIVE Clinical trials to date have not provided definitive evidence regarding the effects
of glucose lowering with coronary heart disease (CHD) risk among diabetic patients …

OBJECTIVE Poor glycemic control is related to vascular events in patients with type 2
diabetes, but the presence of vascular disease might influence this relation. We evaluated …

Background Chronic hyperglycemia has been hypothesized to contribute to coronary heart
disease (CHD), but the extent to which hemoglobin A 1c (HbA 1c) level, a marker of long …

We studied the cross-sectional relationship between HbA1c and cardiovascular disease
(CVD) in the survivors of the original cohort of the Framingham Heart Study (n= 1045) …

OBJECTIVE Diabetes and hypertension often co-occur and share risk factors. Hypertension
is known to predict diabetes. However, hyperglycemia also may be independently …

OBJECTIVE Associations between HbA1c and cardiovascular diseases (CVD) have been
reported mainly in Western countries. It is not clear whether HbA1c measurements are …

AIMS: To assess to which extent lowering the level of HbA1c influences the 10-year risk of
coronary heart disease (CHD) and all-cause mortality in patients with type 2 diabetes …

OBJECTIVE Glycosylated hemoglobin (HbA1c) recently has been recommended for the
diagnosis of diabetes by the American Diabetes Association, but its value in the prediction of …

Eeg‐Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson A‐M, Gudbjörnsdóttir S,
Eliasson B (Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg …

Aims/hypothesis Heart failure (HF) incidence in diabetes in both the presence and absence
of CHD is rising. Prospective population-based studies can help describe the relationship …